December 18 2020
Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration
Tokyo, Japan, and Nanjing, China, December 18, 2020 -- Teijin Pharma Limited (“Teijin Pharma”), the core company of the Teijin Group’s healthcare business headquartered in Tokyo, Japan, and TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in Nanjing, China, jointly announced that they have entered into a strategic collaboration agreement for joint research and development of the innovative drugs in the target fields of oncology and inflammatory diseases.
View
